Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

  • The following term was not found in PubMed: Darwono.
1.

Synergistic inhibition of melanoma xenografts by Brequinar sodium and Doxorubicin.

Dorasamy MS, Ab A, Nellore K, Wong PF.

Biomed Pharmacother. 2019 Feb;110:29-36. doi: 10.1016/j.biopha.2018.11.010. Epub 2018 Nov 17.

2.

VES: Bezug zum Herztodrisiko nur bei KHK.

Ab.

MMW Fortschr Med. 2018 Jun;160(11):16. doi: 10.1007/s15006-018-0603-0. German. No abstract available.

PMID:
29892878
3.

A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells.

Kovtun Y, Jones GE, Adams S, Harvey L, Audette CA, Wilhelm A, Bai C, Rui L, Laleau R, Liu F, Ab O, Setiady Y, Yoder NC, Goldmacher VS, Chari RVJ, Pinkas J, Chittenden T.

Blood Adv. 2018 Apr 24;2(8):848-858. doi: 10.1182/bloodadvances.2018017517.

4.

A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody-Drug Conjugates (ADCs).

Miller ML, Shizuka M, Wilhelm A, Salomon P, Reid EE, Lanieri L, Sikka S, Maloney EK, Harvey L, Qiu Q, Archer KE, Bai C, Vitharana D, Harris L, Singh R, Ponte JF, Yoder NC, Kovtun Y, Lai KC, Ab O, Pinkas J, Keating TA, Chari RVJ.

Mol Cancer Ther. 2018 Mar;17(3):650-660. doi: 10.1158/1535-7163.MCT-17-0940. Epub 2018 Feb 13.

5.

NMR in structure-based drug design.

Carneiro MG, Ab E, Theisgen S, Siegal G.

Essays Biochem. 2017 Nov 8;61(5):485-493. doi: 10.1042/EBC20170037. Print 2017 Nov 8. Review.

PMID:
29118095
6.

Automatic Assignment of Methyl-NMR Spectra of Supramolecular Machines Using Graph Theory.

Pritišanac I, Degiacomi MT, Alderson TR, Carneiro MG, Ab E, Siegal G, Baldwin AJ.

J Am Chem Soc. 2017 Jul 19;139(28):9523-9533. doi: 10.1021/jacs.6b11358. Epub 2017 Jul 10.

PMID:
28691806
7.

abcd.

Ab.

J Invertebr Pathol. 2017 Jul;147:23-36. doi: 10.1016/j.jip.2017.06.008. Review. No abstract available.

PMID:
28648173
8.

Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates.

Sun X, Ponte JF, Yoder NC, Laleau R, Coccia J, Lanieri L, Qiu Q, Wu R, Hong E, Bogalhas M, Wang L, Dong L, Setiady Y, Maloney EK, Ab O, Zhang X, Pinkas J, Keating TA, Chari R, Erickson HK, Lambert JM.

Bioconjug Chem. 2017 May 17;28(5):1371-1381. doi: 10.1021/acs.bioconjchem.7b00062. Epub 2017 Apr 13.

PMID:
28388844
9.

Sind es wirklich Hämorrhoiden?

Ab.

MMW Fortschr Med. 2017 Jan;159(1):10-12. doi: 10.1007/s15006-017-9133-4. German. No abstract available.

PMID:
28097581
10.

Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models.

Ponte JF, Ab O, Lanieri L, Lee J, Coccia J, Bartle LM, Themeles M, Zhou Y, Pinkas J, Ruiz-Soto R.

Neoplasia. 2016 Dec;18(12):775-784. doi: 10.1016/j.neo.2016.11.002. Epub 2016 Nov 25.

11.

Single Lysis-Salting Out Method of Genomic DNA Extraction From Dried Blood Spots.

Shaik M, Shivanna DK, Kamate M, Ab V, Tp KV.

J Clin Lab Anal. 2016 Nov;30(6):1009-1012. doi: 10.1002/jcla.21972. Epub 2016 Apr 13.

PMID:
27074880
12.

[Metformin - an anti-carcinogenesis drug?].

Ab.

MMW Fortschr Med. 2016 Mar 31;158(6):18. doi: 10.1007/s15006-016-7973-y. German. No abstract available.

PMID:
27084134
13.

[Supplementation reduces mortality].

Ab.

MMW Fortschr Med. 2015 Mar 19;157(5):30. doi: 10.1007/s15006-015-2810-2. German. No abstract available.

PMID:
26014998
14.

IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors.

Ab O, Whiteman KR, Bartle LM, Sun X, Singh R, Tavares D, LaBelle A, Payne G, Lutz RJ, Pinkas J, Goldmacher VS, Chittenden T, Lambert JM.

Mol Cancer Ther. 2015 Jul;14(7):1605-13. doi: 10.1158/1535-7163.MCT-14-1095. Epub 2015 Apr 22.

15.

Solution structure of RING finger-like domain of retinoblastoma-binding protein-6 (RBBP6) suggests it functions as a U-box.

Kappo MA, Ab E, Hassem F, Atkinson RA, Faro A, Muleya V, Mulaudzi T, Poole JO, McKenzie JM, Chibi M, Moolman-Smook JC, Rees DJ, Pugh DJ.

J Biol Chem. 2012 Mar 2;287(10):7146-58. doi: 10.1074/jbc.M110.217059. Epub 2011 Nov 29.

16.

Atomic-resolution three-dimensional structure of HET-s(218-289) amyloid fibrils by solid-state NMR spectroscopy.

Van Melckebeke H, Wasmer C, Lange A, Ab E, Loquet A, Böckmann A, Meier BH.

J Am Chem Soc. 2010 Oct 6;132(39):13765-75. doi: 10.1021/ja104213j.

PMID:
20828131
17.

Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.

Kobayashi M, Retra K, Figaroa F, Hollander JG, Ab E, Heetebrij RJ, Irth H, Siegal G.

J Biomol Screen. 2010 Sep;15(8):978-89. doi: 10.1177/1087057110375614.

PMID:
20817886
18.

Application of fragment-based drug discovery to membrane proteins: identification of ligands of the integral membrane enzyme DsbB.

Früh V, Zhou Y, Chen D, Loch C, Ab E, Grinkova YN, Verheij H, Sligar SG, Bushweller JH, Siegal G.

Chem Biol. 2010 Aug 27;17(8):881-91. doi: 10.1016/j.chembiol.2010.06.011.

19.

Antibody-maytansinoid conjugates designed to bypass multidrug resistance.

Kovtun YV, Audette CA, Mayo MF, Jones GE, Doherty H, Maloney EK, Erickson HK, Sun X, Wilhelm S, Ab O, Lai KC, Widdison WC, Kellogg B, Johnson H, Pinkas J, Lutz RJ, Singh R, Goldmacher VS, Chari RV.

Cancer Res. 2010 Mar 15;70(6):2528-37. doi: 10.1158/0008-5472.CAN-09-3546. Epub 2010 Mar 2.

20.

Structure of the DNA-bound BRCA1 C-terminal region from human replication factor C p140 and model of the protein-DNA complex.

Kobayashi M, Ab E, Bonvin AM, Siegal G.

J Biol Chem. 2010 Mar 26;285(13):10087-97. doi: 10.1074/jbc.M109.054106. Epub 2010 Jan 15.

21.

Neonatal tooth in fraternal twins: a case report.

Ar P, Gr R, Os R, J Kurthukoti A, Ab S.

Int J Clin Pediatr Dent. 2009 May;2(2):40-4. doi: 10.5005/jp-journals-10005-1028. Epub 2009 Aug 26.

22.

Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study.

AB E, Denig P, van Vliet T, Dekker JH.

BMC Fam Pract. 2009 Apr 21;10:24. doi: 10.1186/1471-2296-10-24.

23.

Solution structure and characterization of the DNA-binding activity of the B3BP-Smr domain.

Diercks T, AB E, Daniels MA, de Jong RN, Besseling R, Kaptein R, Folkers GE.

J Mol Biol. 2008 Nov 28;383(5):1156-70. doi: 10.1016/j.jmb.2008.09.005. Epub 2008 Sep 12.

PMID:
18804481
24.

Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1): a potential therapeutic modality implication against natural killer/T cell malignancy.

Ishitsuka K, Jimi S, Goldmacher VS, Ab O, Tamura K.

Br J Haematol. 2008 Apr;141(1):129-31. doi: 10.1111/j.1365-2141.2008.07000.x. Epub 2008 Feb 12. No abstract available.

PMID:
18279455
25.

Structure and DNA binding of the human Rtf1 Plus3 domain.

de Jong RN, Truffault V, Diercks T, Ab E, Daniels MA, Kaptein R, Folkers GE.

Structure. 2008 Jan;16(1):149-59. doi: 10.1016/j.str.2007.10.018.

26.

Integration of fragment screening and library design.

Siegal G, Ab E, Schultz J.

Drug Discov Today. 2007 Dec;12(23-24):1032-9. Epub 2007 Oct 2. Review.

PMID:
18061882
27.

The high resolution NMR structure of the third SH3 domain of CD2AP.

Ortega Roldan JL, Romero Romero ML, Ora A, Ab E, Lopez Mayorga O, Azuaga AI, van Nuland NA.

J Biomol NMR. 2007 Dec;39(4):331-6. Epub 2007 Oct 9.

PMID:
17922258
28.

The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3.

Casares S, Ab E, Eshuis H, Lopez-Mayorga O, van Nuland NA, Conejero-Lara F.

BMC Struct Biol. 2007 Apr 2;7:22.

29.

NMR in the SPINE Structural Proteomics project.

Ab E, Atkinson AR, Banci L, Bertini I, Ciofi-Baffoni S, Brunner K, Diercks T, Dötsch V, Engelke F, Folkers GE, Griesinger C, Gronwald W, Günther U, Habeck M, de Jong RN, Kalbitzer HR, Kieffer B, Leeflang BR, Loss S, Luchinat C, Marquardsen T, Moskau D, Neidig KP, Nilges M, Piccioli M, Pierattelli R, Rieping W, Schippmann T, Schwalbe H, Travé G, Trenner J, Wöhnert J, Zweckstetter M, Kaptein R.

Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1150-61. Epub 2006 Sep 19. Review.

PMID:
17001092
30.

Structural characterization of Spo0E-like protein-aspartic acid phosphatases that regulate sporulation in bacilli.

Grenha R, Rzechorzek NJ, Brannigan JA, de Jong RN, Ab E, Diercks T, Truffault V, Ladds JC, Fogg MJ, Bongiorni C, Perego M, Kaptein R, Wilson KS, Folkers GE, Wilkinson AJ.

J Biol Chem. 2006 Dec 8;281(49):37993-8003. Epub 2006 Sep 25.

31.

Solution structure of a chemosensory protein from the desert locust Schistocerca gregaria.

Tomaselli S, Crescenzi O, Sanfelice D, Ab E, Wechselberger R, Angeli S, Scaloni A, Boelens R, Tancredi T, Pelosi P, Picone D.

Biochemistry. 2006 Sep 5;45(35):10606-13.

PMID:
16939212
32.

Direct use of unassigned resonances in NMR structure calculations with proxy residues.

AB E, Pugh DJ, Kaptein R, Boelens R, Bonvin AM.

J Am Chem Soc. 2006 Jun 14;128(23):7566-71.

PMID:
16756312
33.

DWNN, a novel ubiquitin-like domain, implicates RBBP6 in mRNA processing and ubiquitin-like pathways.

Pugh DJ, Ab E, Faro A, Lutya PT, Hoffmann E, Rees DJ.

BMC Struct Biol. 2006 Jan 5;6:1.

34.

First Report in Sweden of Downy Mildew on Parsley Caused by Plasmopara petroselini.

Amein T, Olsson CHB, Wikström M, Findus R, Ab D, Wright SAI.

Plant Dis. 2006 Jan;90(1):111. doi: 10.1094/PD-90-0111A.

PMID:
30786493
35.

The structure of the human ERCC1/XPF interaction domains reveals a complementary role for the two proteins in nucleotide excision repair.

Tripsianes K, Folkers G, Ab E, Das D, Odijk H, Jaspers NG, Hoeijmakers JH, Kaptein R, Boelens R.

Structure. 2005 Dec;13(12):1849-58.

36.

Solution structure of the human ubiquitin-specific protease 15 DUSP domain.

de Jong RN, Ab E, Diercks T, Truffault V, Daniëls M, Kaptein R, Folkers GE.

J Biol Chem. 2006 Feb 24;281(8):5026-31. Epub 2005 Nov 18.

37.

The structure of bypass of forespore C, an intercompartmental signaling factor during sporulation in Bacillus.

Patterson HM, Brannigan JA, Cutting SM, Wilson KS, Wilkinson AJ, Ab E, Diercks T, de Jong RN, Truffault V, Folkers GE, Kaptein R.

J Biol Chem. 2005 Oct 28;280(43):36214-20. Epub 2005 Jul 27.

38.

Detrusor overactivity in spina bifida: how long does it need to be treated?

Ab E, Dik P, Klijn AJ, van Gool JD, de Jong TP.

Neurourol Urodyn. 2004;23(7):685-8.

PMID:
15382196
39.

Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.

Miller ML, Roller EE, Zhao RY, Leece BA, Ab O, Baloglu E, Goldmacher VS, Chari RV.

J Med Chem. 2004 Sep 23;47(20):4802-5.

PMID:
15369381
40.

Effect of fluoride mouth rinse on fluoride releasing and recharging from aesthetic dental materials.

Han L, Cv E, Li M, Niwano K, Ab N, Okamoto A, Honda N, Iwaku M.

Dent Mater J. 2002 Dec;21(4):285-95.

41.

Lymphocyte subsets and assessment of cancer risk in renal transplant recipients.

Ducloux D, Carron PL, Motte G, Ab A, Rebibou JM, Bresson-Vautrin C, Tiberghien P, Saint-Hillier Y, Chalopin JM.

Transpl Int. 2002 Sep;15(8):393-6. Epub 2002 Aug 21.

PMID:
12221457
42.

Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen.

Tansho S, Ab S, Mizutani S, Ono Y, Takesako K, Yamaguchi H.

Microbiol Immunol. 2002;46(5):307-11.

43.

[Urine incontinence in childhood; the importance of a good micturition history].

Ab E, van Diemen-Steenvoorde JA, de Jong TP.

Ned Tijdschr Geneeskd. 2002 Feb 2;146(5):193-6. Dutch.

PMID:
11851076
44.

NMR structure of cysteinyl-phosphorylated enzyme IIB of the N,N'-diacetylchitobiose-specific phosphoenolpyruvate-dependent phosphotransferase system of Escherichia coli.

Ab E, Schuurman-Wolters GK, Nijlant D, Dijkstra K, Saier MH, Robillard GT, Scheek RM.

J Mol Biol. 2001 May 18;308(5):993-1009.

PMID:
11352587
45.

[Allele polymorphism of the dopamine transporter gene in group of patients with endogenous psychotic diseases: association with pathological syndromes].

Aksenova MG, Golimbet VE, Alfimova MV, Trubnikov VI, Ab OV, Iazykov KG, Nosikov VV.

Mol Biol (Mosk). 2000 Jul-Aug;34(4):696-700. Russian. No abstract available.

PMID:
11042860
46.

[Allelic polymorphism at the TAQIB locus of the dopamine D2 receptor gene in groups of patients with endogenous psychoses].

Aksenova MG, Ab OV, Golimbet VE, Abramova LI, Orlova VA, Kaleda VG, Oleĭchik IV, Nosikov VV.

Mol Biol (Mosk). 2000 May-Jun;34(3):386-9. Russian. No abstract available.

PMID:
10867915
47.
48.

[Primary peritonitis due to Streptococcus pneumoniae in childhood].

van Houten MA, Ab E, Zwierstra RP, Kimpen JL.

Ned Tijdschr Geneeskd. 1998 Apr 4;142(14):793-6. Dutch.

PMID:
9646612
50.

The chicken CCAAT/enhancer binding protein alpha gene. Cloning, characterisation and tissue distribution.

Calkhoven CF, Gringhuis SI, Ab G.

Gene. 1997 Sep 1;196(1-2):219-29.

PMID:
9322761

Supplemental Content

Support Center